GCVRZ
Sanofi Contingent Value Rights
GCVRZ
GCVRZ
Delisted
GCVRZ was delisted on the 3rd of March, 2020.
105 hedge funds and large institutions have $57.4M invested in Sanofi Contingent Value Rights in 2017 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 15 increasing their positions, 15 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
33% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 15
Holders
105
Holding in Top 10
1
Calls
$591K
Puts
–
Top Buyers
| 1 | +$1.37M | |
| 2 | +$947K | |
| 3 | +$190K | |
| 4 |
NGA
New Generation Advisors
Manchester,
Massachusetts
|
+$163K |
| 5 |
JGC
J. Goldman & Co
New York
|
+$76K |
Top Sellers
| 1 | -$961K | |
| 2 | -$560K | |
| 3 | -$540K | |
| 4 |
Millennium Management
New York
|
-$180K |
| 5 |
WA
Whitebox Advisors
Minneapolis,
Minnesota
|
-$85.7K |